| 631688 | Hcas2 | Hepatocarcinoma susceptibility QTL 2 | 3 | 0.0001 | liver integrity trait (VT:0010547) | liver tumorous lesion number (CMO:0001068) | 1 | 5925874 | 115540829 | Rat |
| 1357397 | Bw41 | Body weight QTL 41 | 4.19 | 0.0001 | body mass (VT:0001259) | body weight (CMO:0000012) | 1 | 22340647 | 49361612 | Rat |
| 1578650 | Bmd6 | Bone mineral density QTL 6 | 12.2 | | femur mineral mass (VT:0010011) | total volumetric bone mineral density (CMO:0001728) | 1 | 509108 | 43284926 | Rat |
| 1578651 | Bmd7 | Bone mineral density QTL 7 | 14.2 | | femur mineral mass (VT:0010011) | compact volumetric bone mineral density (CMO:0001730) | 1 | 509108 | 43284926 | Rat |
| 2313062 | Bmd73 | Bone mineral density QTL 73 | 3.9 | 0.0001 | tibia mineral mass (VT:1000283) | compact volumetric bone mineral density (CMO:0001730) | 1 | 11481312 | 82174945 | Rat |
| 1554320 | Bmd1 | Bone mineral density QTL 1 | 12.2 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 1 | 509108 | 86060548 | Rat |
| 2313065 | Bss67 | Bone structure and strength QTL 67 | 3.1 | 0.0001 | tibia area (VT:1000281) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat |
| 7421626 | Bp360 | Blood pressure QTL 360 | | 0.001 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 1 | 4393289 | 49393289 | Rat |
| 1357400 | Bw62 | Body weight QTL62 | 4.05 | | inguinal fat pad mass (VT:0010424) | inguinal fat pad weight to body weight ratio (CMO:0001253) | 1 | 22340647 | 67340647 | Rat |
| 2313070 | Bss52 | Bone structure and strength QTL 52 | 4.4 | 0.0001 | body length (VT:0001256) | body length (CMO:0000013) | 1 | 1 | 32356093 | Rat |
| 1357401 | Bw43 | Body weight QTL 43 | 3.75 | | body mass (VT:0001259) | body weight (CMO:0000012) | 1 | 22340647 | 49361612 | Rat |
| 2313069 | Bss68 | Bone structure and strength QTL 68 | 2.9 | 0.0001 | tibia size trait (VT:0100001) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat |
| 631495 | Bp96 | Blood pressure QTL 96 | 4.52 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 22340647 | 102268831 | Rat |
| 631494 | Bp95 | Blood pressure QTL 95 | 40 | 0.0001 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 16206210 | 49268520 | Rat |
| 2313075 | Bss66 | Bone structure and strength QTL 66 | 3.4 | 0.0001 | tibia length (VT:0004357) | tibia length (CMO:0000450) | 1 | 11481312 | 82174945 | Rat |
| 5684998 | Bss101 | Bone structure and strength QTL 101 | 3.6 | | tibia strength trait (VT:1000284) | tibia ultimate force (CMO:0001734) | 1 | 15431621 | 49361612 | Rat |
| 5684999 | Bss102 | Bone structure and strength QTL 102 | 5.5 | 7e-07 | tibia strength trait (VT:1000284) | tibia stiffness (CMO:0001735) | 1 | 15431621 | 49361612 | Rat |
| 1300167 | Hrtrt2 | Heart rate QTL 2 | 4.35 | | heart pumping trait (VT:2000009) | heart rate (CMO:0000002) | 1 | 11481312 | 75088344 | Rat |
| 2313077 | Bss69 | Bone structure and strength QTL 69 | 3.5 | 0.0001 | tibia strength trait (VT:1000284) | bone polar moment of inertia (CMO:0001558) | 1 | 11481312 | 82174945 | Rat |
| 2317755 | Glom22 | Glomerulus QTL 22 | 3.8 | | urine protein amount (VT:0005160) | urine protein level (CMO:0000591) | 1 | 11481482 | 32355910 | Rat |
| 1578756 | Iddm22 | Insulin dependent diabetes mellitus QTL 22 | 2.7 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 1 | 11835181 | 56835181 | Rat |
| 631508 | Sald1 | Serum aldosterone level QTL 1 | 3.7 | | blood aldosterone amount (VT:0005346) | serum aldosterone level (CMO:0000487) | 1 | 9856001 | 54856001 | Rat |
| 1331785 | Rf27 | Renal function QTL 27 | 4.643 | | urine sodium amount (VT:0006274) | urine sodium level (CMO:0000129) | 1 | 28879780 | 78430678 | Rat |
| 2313090 | Bmd69 | Bone mineral density QTL 69 | 4.4 | 0.0001 | tibia mineral mass (VT:1000283) | compact volumetric bone mineral density (CMO:0001730) | 1 | 1 | 32356093 | Rat |
| 724520 | Bp145 | Blood pressure QTL 145 | 2.1 | 0.0024 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 20784828 | 65784828 | Rat |
| 1558642 | Prcr2 | Prostate cancer resistance QTL 2 | 4.3 | | prostate integrity trait (VT:0010571) | area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio (CMO:0000899) | 1 | 20763158 | 44095856 | Rat |
| 2313092 | Bmd72 | Bone mineral density QTL 72 | 2.5 | 0.0001 | tibia mineral mass (VT:1000283) | total volumetric bone mineral density (CMO:0001728) | 1 | 11481312 | 82174945 | Rat |
| 2313097 | Bss70 | Bone structure and strength QTL 70 | 3.5 | 0.0001 | tibia strength trait (VT:1000284) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat |
| 738020 | Pia8 | Pristane induced arthritis QTL 8 | 4.7 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 1 | 1 | 65833076 | Rat |
| 1600360 | Mcs16 | Mammary carcinoma susceptibility QTL 16 | 2.4 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 1 | 2244390 | 43433040 | Rat |
| 1578669 | Bss9 | Bone structure and strength QTL 9 | 6.3 | | femur morphology trait (VT:0000559) | bone trabecular cross-sectional area (CMO:0002311) | 1 | 509108 | 43284926 | Rat |
| 2302038 | Pia31 | Pristane induced arthritis QTL 31 | 5.5 | 0.001 | blood autoantibody amount (VT:0003725) | serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111) | 1 | 10992065 | 55992065 | Rat |
| 634353 | Rends2 | Renal damage susceptibility QTL 2 | | 0.05 | kidney blood vessel morphology trait (VT:0000530) | organ lesion measurement (CMO:0000677) | 1 | 19333571 | 56983283 | Rat |
| 2313053 | Bss51 | Bone structure and strength QTL 51 | 3.8 | 0.0001 | tibia length (VT:0004357) | tibia length (CMO:0000450) | 1 | 1 | 32356093 | Rat |
